Transcription of The Globalisation of the Pharmaceutical Industry Monograph
{{id}} {{{paragraph}}}
The Globalisation of the Pharmaceutical IndustryPHARMACEUTICALS POLICY AND LAWP harmaceuticals Policy and LawVolume 18 Earlier published in this Valverde and G. Fracchia (Eds), Focus on Pharmaceutical Valverde (Ed), The Problem of Herbal Medicines Legal Valverde (Ed), The European Regulation on Orphan Medicinal Valverde (Ed), Information Society in C. Huttin (Ed), Challenges for Pharmaceutical Policies in the 21st Valverde and P. Weissenberg (Eds), The Challenges of the New EU Pharmaceutical Valverde (Ed), Blood, Plasma and Plasma Proteins: A Unique Contribution to Modern Valverde (Ed), Responsibilities in the Efficient Use of Medicinal (1,2). Valverde (Ed), 2050: A Changing Europe. Demographic Crisis and Baby Friend (3,4). Valverde (Ed), Key Issues in Pharmaceuticals Valverde and D. Watters (Eds), Focus on (1,2). Valverde and A. Ceci (Eds), The EU Paediatric (3).
Pharmaceuticals Policy and Law 18 (2016) 1–4 1 DOI 10.3233/PPL-160427 IOS Press Editorial – The innovation and access to landscape Jose Luis Valverdea,∗ and Eduardo Pisanib aChair Jean Monnet of EU Law, Granada, Spain bInternational Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Geneva, Switzerland
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}